Antibiotic treatment duration and prevention of complications in neonatal Staphylococcus aureus bacteraemia
- PMID: 26320613
- DOI: 10.1016/j.jhin.2015.07.002
Antibiotic treatment duration and prevention of complications in neonatal Staphylococcus aureus bacteraemia
Abstract
Background: In adults with Staphylococcus aureus bacteraemia, short duration of effective antibiotic treatment is associated with increased risk of complications and recurrence. The optimum duration of treatment for neonates is unknown and practice varies widely.
Aim: To relate the duration of treatment of neonatal S. aureus bacteraemia to prevention of complications and recurrence.
Methods: Retrospective cohort study of confirmed S. aureus bacteraemia occurring over a 10 year period in two large tertiary neonatal units. Neonatal patients developing confirmed S. aureus bacteraemia between birth and discharge from the neonatal unit were identified from microbiology department records. Clinical details obtained from case notes included demographics, duration of antibiotics and clinical outcomes. Recurrence was determined from laboratory and clinical records. Adverse outcomes were related to duration of antibiotic therapy.
Findings: A total of 90 infants had S. aureus bacteraemia, of which six were meticillin-resistant S. aureus (7%). Median gestation was 27 weeks (range: 23-41), birth weight 846 g (434-3840) and postnatal age 16 days (0-116). Adverse outcomes were found in 44%, with death in 8%. Median duration of appropriate antibiotics was 19 days (range: 0-54). There were no cases of recurrent bacteraemia after finishing antibiotics. There was no relationship between antibiotic duration and complications.
Conclusion: Neonatal S. aureus bacteraemia mainly affected preterm neonates and had a significant morbidity and mortality. Recurrent bacteraemia was rare, irrespective of treatment duration. For neonatal unit patients with S. aureus bacteraemia, antibiotic therapy for 14 days in uncomplicated cases may be sufficient to prevent recurrence, with longer treatment justified if there is inadequate source control.
Keywords: Antibiotics; Complications; Infant newborn; Septicaemia; Staphylococcus aureus.
Copyright © 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.Lancet Infect Dis. 2014 Oct;14(10):967-75. doi: 10.1016/S1473-3099(14)70876-X. Epub 2014 Aug 31. Lancet Infect Dis. 2014. PMID: 25185461
-
Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review.J Infect. 2006 Dec;53(6):387-93. doi: 10.1016/j.jinf.2005.11.185. Epub 2006 Feb 14. J Infect. 2006. PMID: 16476482
-
Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.J Infect. 2011 May;62(5):339-46. doi: 10.1016/j.jinf.2011.03.003. Epub 2011 Mar 12. J Infect. 2011. PMID: 21402101
-
Staphylococcus aureus bloodstream infections: definitions and treatment.Clin Infect Dis. 2009 May 15;48 Suppl 4:S254-9. doi: 10.1086/598186. Clin Infect Dis. 2009. PMID: 19374581 Review.
-
Future strategies for treating Staphylococcus aureus bloodstream infections.Clin Microbiol Infect. 2008 Mar;14 Suppl 2:26-34. doi: 10.1111/j.1469-0691.2008.01924.x. Clin Microbiol Infect. 2008. PMID: 18226087 Review.
Cited by
-
[Research advances in rational use of antibiotics in neonates].Zhongguo Dang Dai Er Ke Za Zhi. 2018 Oct;20(10):876-880. doi: 10.7499/j.issn.1008-8830.2018.10.019. Zhongguo Dang Dai Er Ke Za Zhi. 2018. PMID: 30369368 Free PMC article. Chinese.
-
A retrospective study (2001-2017) of acute and chronic morbidity and mortality associated with Staphylococcus aureus bacteraemia in a tertiary neonatal intensive care unit.Ir J Med Sci. 2019 Nov;188(4):1297-1301. doi: 10.1007/s11845-019-01992-y. Epub 2019 Feb 25. Ir J Med Sci. 2019. PMID: 30805770
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical